Abstract
Growth factors control cellular growth, proliferation, and differentiation and may have therapeutic applications. In this study, we focus on Meteorin which is a member of a largely uncharacterized evolutionary conserved two-member growth factor family. Our analysis shows that Meteorin is expressed in the central nervous system both during development and in adult mice. Detailed immunohistological analysis of the adult mouse brain reveals that Meteorin is highly expressed in Bergmann glia and in a few discrete neuronal populations residing in the superior colliculus, the ocular motor nucleus, the raphe and pontine nuclei, and in various thalamic nuclei. In addition, low levels of Meteorin is found in astrocytes (S100β+, OX42−) distributed ubiquitously throughout the brain. Meteorin was cloned and recombinant protein purified allowing N-terminal sequencing and mass spectrometric analysis showing that Meteorin is secreted as an unmodified monomer. This form is bioactive as it induces neurite outgrowth from dorsal root ganglions in vitro. Intrastriatal protein injection and lentiviral studies in vivo showed that Meteorin is a highly diffusible molecule in the brain and cellular uptake is apparent in specific populations which may carry the receptor. In summary, we provide a comprehensive expression analysis and have made and thoroughly validated molecular tools to help investigate the therapeutic potential of Meteorin.
Similar content being viewed by others
Abbreviations
- 5HT:
-
5-Hydroxytryptamine
- CDNF:
-
Conserved dopamine neurotrophic factor
- ChAT:
-
Choline acetyltransferase
- ESI-MS:
-
Electrospray ionization mass spectrometry
- GDNF:
-
Glial-derived neurotrophic factor
- GFAP:
-
Glial fibrillary acidic protein
- IHC:
-
Immunohistochemistry
- ISH:
-
In situ hybridization
- LC-ESI-MS/MS:
-
Liquid chromatography electrospray ionization tandem mass spectrometry
- MALDI-TOF:
-
Matrix-assisted laser desorption/ionization time-of-flight
- METRN:
-
Meteorin, glial cell differentiation regulator
- NGF:
-
Nerve growth factor
- RP:
-
Reverse phase
- SC:
-
Superior colliculus
References
Bendtsen, J. D., Nielsen, H., von Heijne, G., & Brunak, S. (2004). Improved prediction of signal peptides: SignalP 3.0. Journal of Molecular Biology, 340, 783–795. doi:10.1016/j.jmb.2004.05.028.
Ekestern, E. (2004). Neurotrophic factors and amyotrophic lateral sclerosis. Neuro-Degenerative Diseases, 1, 88–100. doi:10.1159/000080049.
Evans, J. R., & Barker, R. A. (2008). Neurotrophic factors as a therapeutic target for Parkinson's disease. Expert Opinion on Therapeutic Targets, 12, 437–447. doi:10.1517/14728222.12.4.437.
Hamilton, J. F., Morrison, P. F., Chen, M. Y., Harvey-White, J., Pernaute, R. S., Phillips, H., et al. (2001). Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin. Experimental Neurology, 168, 155–161. doi:10.1006/exnr.2000.7571.
Jensen, M. L., Timmermann, D. B., Johansen, T. H., Schousboe, A., Varming, T., & Ahring, P. K. (2002). The beta subunit determines the ion selectivity of the GABAA receptor. The Journal of Biological Chemistry, 277, 41438–41447. doi:10.1074/jbc.M205645200.
Jorgensen, J. R., Juliusson, B., Henriksen, K. F., Hansen, C., Knudsen, S., Petersen, T. N., et al. (2006). Identification of novel genes regulated in the developing human ventral mesencephalon. Experimental Neurology, 198, 427–437. doi:10.1016/j.expneurol.2005.12.023.
Leander, J. J., Dago, L., Tornoe, J., Rosenblad, C., & Kusk, P. (2005). A new versatile and compact lentiviral vector. Molecular Biotechnology, 29, 47–56. doi:10.1385/MB:29:1:47.
Lein, E. S., et al. (2007). Genome-wide atlas of gene expression in the adult mouse brain. Nature, 445, 168–176. doi:10.1038/nature05453.
Lindholm, P., Voutilainen, M. H., Lauren, J., Peranen, J., Leppanen, V. M., Andressoo, J. O., et al. (2007). Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature, 448, 73–77. doi:10.1038/nature05957.
Lindvall, O., & Wahlberg, L. U. (2008). Encapsulated cell biodelivery of GDNF: A novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease. Experimental Neurology, 209, 82–88. doi:10.1016/j.expneurol.2007.08.019.
Nakari-Setala, T., Aro, N., Kalkkinen, N., Alatalo, E., & Penttila, M. (1996). Genetic and biochemical characterization of the Trichoderma reesei hydrophobin HFBI. European Journal of Biochemistry, 235, 248–255. doi:10.1111/j.1432-1033.1996.00248.x.
Nishino, J., Yamashita, K., Hashiguchi, H., Fujii, H., Shimazaki, T., & Hamada, H. (2004). Meteorin: A secreted protein that regulates glial cell differentiation and promotes axonal extension. The EMBO Journal, 23, 1998–2008. doi:10.1038/sj.emboj.7600202.
Park, J. A., Lee, H. S., Ko, K. J., Park, S. Y., Kim, J. H., Choe, G., et al. (2008). Meteorin regulates angiogenesis at the gliovascular interface. Glia, 56, 247–258. doi:10.1002/glia.20600.
Poutanen, M., Salusjarvi, L., Ruohonen, L., Penttila, M., & Kalkkinen, N. (2001). Use of matrix-assisted laser desorption/ionization time-of-flight mass mapping and nanospray liquid chromatography/electrospray ionization tandem mass spectrometry sequence tag analysis for high sensitivity identification of yeast proteins separated by two-dimensional gel electrophoresis. Rapid Communications in Mass Spectrometry, 15, 1685–1692. doi:10.1002/rcm.424.
Schindowski, K., Belarbi, K., & Buee, L. (2008). Neurotrophic factors in Alzheimer's disease: Role of axonal transport. Genes Brain & Behavior, 7(Suppl 1), 43–56.
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996). Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Analytical Chemistry, 68, 850–858. doi:10.1021/ac950914h.
Slemmon, J. R., Danho, W., Hempstead, J. L., & Morgan, J. I. (1985). Cerebellin: A quantifiable marker for Purkinje cell maturation. Proceedings of the National Academy of Sciences of the United States of America, 82, 7145–7148. doi:10.1073/pnas.82.20.7145.
Sun, P. D., & Davies, D. R. (1995). The cystine-knot growth-factor superfamily. Annual Review of Biophysics and Biomolecular Structure, 24, 269–291. doi:10.1146/annurev.bb.24.060195.001413.
Thompson, L., Barraud, P., Andersson, E., Kirik, D., & Bjorklund, A. (2005). Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. The Journal of Neuroscience, 25, 6467–6477. doi:10.1523/JNEUROSCI.1676-05.2005.
Tuszynski, M. H. (2007). Nerve growth factor gene delivery: Animal models to clinical trials. Developmental Neurobiology, 67, 1204–1215. doi:10.1002/dneu.20510.
Ylonen, A., Rinne, A., Herttuainen, J., Bogwald, J., Jarvinen, M., & Kalkkinen, N. (1999). Atlantic salmon (Salmo salar L.) skin contains a novel kininogen and another cysteine proteinase inhibitor. European Journal of Biochemistry, 266, 1066–1072. doi:10.1046/j.1432-1327.1999.00950.x.
Acknowledgments
This work was supported by the EU project EuroStemCell (LSHBCT-2003-503005). The Wilhelm Johannsen Centre for Functional Genome Research is established by the Danish National Research Foundation. CKR is supported by Danish Stem Cell Research Doctoral School (DASCDOC). The authors would like to thank Birgitte Romme Larsen, Sanne Tine Asnæs, Hanne Fosmark, Anne Klit Thomsen, Gunilla Rönnholm, and Karen Friis Henriksen for excellent technical assistance and Bengt Mattsson for preparing the illustration of intrastriatal injection in Fig. 6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jørgensen, J.R., Thompson, L., Fjord-Larsen, L. et al. Characterization of Meteorin—An Evolutionary Conserved Neurotrophic Factor. J Mol Neurosci 39, 104–116 (2009). https://doi.org/10.1007/s12031-009-9189-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-009-9189-4